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Abstract
Aims/hypothesis Sugar has been suggested to promote
obesity, diabetes and coronary heart disease (CHD), yet
fruit, despite containing sugars, may also have a low
glycaemic index (GI) and all fruits are generally recom-
mended for good health. We therefore assessed the effect of
fruit with special emphasis on low GI fruit intake in type 2
diabetes.
Methods This secondary analysis involved 152 type 2
diabetic participants treated with glucose-lowering agents
who completed either 6 months of high fibre or low GI
dietary advice, including fruit advice, in a parallel design.
Results Change inlow GI fruit intakerangedfrom−3.1 to2.7
servings/day. The increase in low GI fruit intake significantly
predicted reductions in HbA1c (r=−0.206, p=0.011), systolic
blood pressure (r=−0.183, p=0.024) and CHD risk
(r=−0.213, p=0.008). Change in total fruit intake ranged
from −3.7 to 3.2 servings/day and was not related to study
outcomes. In a regression analysis including the eight major
carbohydrate foods or classes of foods emphasised in the low
GI diet, only low GI fruit and bread contributed indepen-
dently and significantly to predicting change in HbA1c.
Furthermore, comparing the highest with the lowest quartile
of low GI fruit intake, the percentage change in HbA1c was
reduced by −0.5% HbA1c units (95% CI 0.2–0.8 HbA1c
units, p<0.001).
Conclusions/interpretation Low GI fruit consumption as
part of a low GI diet was associated with lower HbA1c,
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Introduction
Increased sugar intake and, more recently, high fructose
consumption, especially from high fructose corn syrup, has
attracted attention for its potential negative impact on health.
Concerns have been raised especially in respect to body
weight control and increased risk of diabetes and coronary
heart disease (CHD) [1–7]. On the other hand, sugars in fruit
are viewed in a very different light and the public are
recommended to eat more fruit, together with vegetables and
wholegrain cereals, as part of general dietary advice in order
to maintain health and avoid specific diseases such as
diabetes, cardiovascular disease and cancer [8–12].
Thisapparentcontradictioninrelationtotheeffectofsugars
may be due in part to the fibre and cell wall structure of fruit,
which limits the rate of sugar absorption in the gastrointestinal
tract resulting in flatter glycaemic responses [13].Thus, a
flatter glycaemic response has been seen after consumption of
whole fruit when compared with fruit puree and even more so
when compared with drinking fruit juice [13, 14].
Fruit in general have a glycaemic index (GI) that ranges
from 56 to 103 GI units (on the bread scale). We
hypothesised that selection of those at the lower end of
the range may provide the greatest benefit in reducing the
overall glycaemic response. As a result we emphasised the
use of low GI fruit in a previously published study
examining the role of a low GI diet in type 2 diabetes.
This study has now provided us with the opportunity to
assess the relation of low GI fruit intake with the metabolic
changes observed as part of the overall low GI diet [15].
Methods
Participants Details of the study protocol have been
reported previously [15]. Recruitment took place from
May 2004 to December 2006, with the last follow-up visit
at the end of May 2007. Of those recruited, 210 were found
to be eligible and were randomised. Eligible participants
were men or postmenopausal women with type 2 diabetes
who were taking oral agents to control their diabetes, with
medications stable for the previous 3 months and who had
HbA1c values at screening between 6.5% and 8.0%
(Table 1). None had clinically significant cardiovascular,
renal or liver disease (alanine transaminase > three times
the upper limit of normal) and none was undergoing
treatment for cancer. Individuals were accepted after
surgery or myocardial infarction providing an event-free
6 month period had elapsed prior to the study. This study is
a secondary analysis, but differs from the original study
[15] in that it focuses on the 152 participants who
completed the study and also provided 7 day food records,
which were used to determine fruit intake.
The study was approved by the research ethics board of
St Michael’s Hospital and the University of Toronto, and
written consent was obtained from all participants.
Protocol In this secondary analysis of completer data from
a previously published study [15], participants were
randomised to one of two parallel 6 month treatments: a
low GI diet or a high cereal fibre diet. During the study,
equally strong emphasis was placed by dietitians on the
potential value of both treatments.
Participants were seen at the Clinical Nutrition and Risk
Factor Modification Center of St Michael’s Hospital, a
University of Toronto Teaching Hospital, at baseline,
weeks 2 and 4, and thereafter at monthly intervals until
the end of the 6 month period. During the first month,
participants received instructions on the diet to which they
were allocated. At all centre visits, participants were
weighed in indoor clothing without shoes and a fasting
blood sample was taken. Blood pressure was measured
seated on three occasions at 1 min intervals using an Omron
automatic sphygmomanometer (OMRON Healthcare, Bur-
lington, ON, Canada) and the mean of the three measure-
ments was taken. In addition, participants brought with
them their 7 day food records covering the week prior to
the visit and these were discussed with the dietitians.
During the study, participants were asked to maintain
their exercise pattern and keep their glucose-lowering
agents constant throughout the study.
Dietary interventions General dietary advice conformed to
the National Cholesterol Education Program Adult Treat-
ment Panel III (NCEP ATP III) and the ADA guidelines
[16] toreducesaturatedfatandcholesterolintakes[17]. Of all
the participants, 84.9% were overweight (BMI ≥25 kg/m
2)
and 50.7% were obese (BMI ≥30 kg/m
2) and wished to lose
weight. They were informed that this was not a weight loss
272 Diabetologia (2011) 54:271–279study but appropriate advice was given on portion size and
fat intake to help them meet their body weight objectives.
Participants were also provided with a checklist with either
low GI or high cereal fibre food options as approximately
15 g carbohydrate servings. The number of carbohydrate
servings prescribed covered 42–43% of total dietary energy.
Three servings of fruit and five servings of vegetables were
encouraged on both treatments. On the low GI treatment, the
carbohydrate intakes emphasised were low GI breads,
breakfast cereals, parboiled rice, pasta, beans, barley, bulgar
and low GI fruit. Temperate climate fruit, which are
generally low GI, were the focus and included apples, pears,
citrus fruit (oranges, tangerines and grapefruit), berries
(strawberries, raspberries, cranberries, blackberries and blue-
berries) and the Prunus family (nectarines, peaches and
plums). On the cereal fibre treatment, the focus was on
wholewheat breads, breakfast cereals and tropical fruit with
glycaemic indices that were closer to that of the average diet,
such as bananas, mangoes, guavas, grapes, raisins, water-
melon and cantaloupe. Low GI or temperate climate fruit had
GI values of <70 GI units (bread scale), with the exception
of blueberries, with a value of 76 GI units, based on recent
values for individuals without diabetes [18]. Higher GI fruit,
predominantly tropical fruit, had values >70 GI units [18].
Participants were also advised against eating fruit recom-
mended on the alternative treatment. Checklists were
completed by participants on a daily basis throughout the
study and 7 day diet records were completed prior to each
visit. Adherence was assessed from the 7 day diet records.
The overall aim was to achieve a 10–20% reduction in GI on
the low GI diet while keeping dietary fibre similar between
treatments.
Characteristic High cereal fibre
(n=73)
Low GI
(n=79)
Significance of difference
p value
Age (years) 62±9 61±10 0.669
Sex (male/female, n/n) 45/28 51/28 0.305/0.553
Weight (kg) 86±16 87±21 0.885
BMI (kg/m
2) 31±5 30±6 0.732
Ethnicity, n (%)
European 46 (63) 57 (72) 0.162
Indian 14 (19) 11 (14) 0.345
Far Eastern 3 (4) 6 (8) 0.254
African 8 (11) 3 (4) 0.113
Hispanic 1 (1) 2 (3) 0.500
Native American 1 (1) 0 (0) 0.500
Smokers, n (%) 2 (3) 8 (10) 0.055
Glucose (mmol/l) 7.56±1.52 7.64±1.75 0.767
HbA1c (%) 7.03±0.46 7.17±0.57 0.100
No. participants <7 36 29 0.229
No. participants ≥7 37 50 0.099
Total cholesterol (mmol/l) 4.24±0.75 4.18±0.95 0.661
LDL-cholesterol (mmol/l) 2.48±0.64 2.47±0.89 0.934
HDL-cholesterol (mmol/l) 1.14±0.28 1.06±0.31 0.103
TG (mmol/l) 1.36±0.71 1.42±0.79 0.643
Systolic blood pressure (mmHg) 128±14 127±16 0.727
Diastolic blood pressure (mmHg) 74±9 73±10 0.846
Duration of diabetes (years) 7±6 9±7 0.062
Hypoglycaemic agents, n (%) 73 (100) 77 (97) 0.403
Thiazolidinedione 25 (34) 25 (32) 0.556
Biguanide 58 (79) 63 (80) 0.358
Sulfonylurea 29 (40) 49 (62) 0.015
Meglitinides (non-sulfonylurea) 2 (3) 1 (1) 0.500
Alpha glucosidase inhibitors 2 (3) 3 (4) 0.500
Cholesterol-lowering medications, n (%) 46 (63) 55 (70) 0.539
Blood pressure medications, n (%) 52 (71) 52 (66) 0.213
Table 1 Baseline characteristics
of study participants
Values are mean ± SD unless
stated otherwise
Differences in categorical
variables were assessed
by binomial tests of equality
Differences in continuous
variables were assessed by
two-sample t test
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hospital routine analytical laboratory by a glucose oxidase
method using a Random Access Analyzer and reagents
(SYNCHRON LX Systems, Beckman Coulter, Brea, CA,
USA) (CV 1.9%). HbA1c was analysed by a designated
HPLC method (Tosoh G7 Automated HPLC Analyzer,
Grove City, OH, USA) (CV 1.7%). Serum was analysed for
total cholesterol, triacylglycerol (TG) and HDL-cholesterol,
also using a Random Access Analyzer (CV 1.5–2.4%).
Diets were assessed for available carbohydrate (total
carbohydrate–fibre) using a computer program based on
US Department of Agriculture data [19].
Statistical analyses The primary outcome was HbA1c,w i t h
glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol,
TG, blood pressure, body weight and CHD risk as secondary
measures. Analyses were undertaken on individuals who
completed the study and also provided diet records at the
start of and during the study (n=152).
Baseline data are expressed as means ± SDs. All other
data are expressed as means (95% CI). All analyses were
carried out using SAS software, version 9.2 [20].
Pearson correlations as well as partial correlations
controlling for body weight change and change in fibre
intake were undertaken to determine the relation of low GI
fruit to measures of glycaemic control and CHD risk. The
data from the two treatments were pooled and both the
absolute differences in servings of fruit, and the carbohy-
drate from fruit expressed as a percentage of the total
carbohydrate, were related to the percentage changes from
baseline in the outcome measures. Overall 10 year CHD
risk was calculated according to the Framingham cardio-
vascular risk equation [21]. In our current analyses, only
raw and frozen fruit were included. We excluded
processed fruit products such as juices, canned fruit and
jams as unmodified fruit was the focus of our assess-
ment. Two-sample Student’s t test was used to assess
differences between treatments at baseline and between
changes across treatments. Binomial tests of equality were
used to assess differences at baseline for categorical
variables.
Participants were also divided into four equal groups based
on the magnitude of the change they made in low GI fruit
intake, expressed as a percentage of daily available carbo-
hydrate from fruit available carbohydrate from fruit  ð ½
total available carbohydrate in the dietÞ 100 : The sig-
nificance of differences between those in the upper quartile
of change in low GI fruit intake vs those in the lowest
quartile was assessed using an ANOVA model (Proc GLM
in SAS version 9.2) [20], with percentage change in
measurements as the response variable.
Finally, to assess the contribution of low GI fruit to the
absolute change in HbA1c, as the primary outcome in the
context of the other major low GI food components, a
regression analysis was undertaken in SAS using an
ANOVA model. In this analysis, the assessment of each
dietary component was carried out in a model adjusted for
change in fibre (g/kJ or kcal) and total fruit intake (% of
available carbohydrate). The eight individual low GI
dietary components were fruit, bread, breakfast cereals,
pasta, beans, parboiled rice, barley and bulgar, each
expressed as a percentage of total carbohydrate.
Results
Of the 210 individuals randomised, 155 completed the
study [15] and dietary records for both pretreatment and
end of treatment were available for 152 participants. At
baseline, individuals taking either high cereal fibre or low
GI diets were similar in terms of physical characteristics,
ethnicity, smoking status, glycaemic and lipid control and
medication use, with the exception of higher sulfonylurea
use by the low GI diet group (Table 1).
Fruit consumption At baseline, participants were consum-
ing 1.4 servings (95% CI 1.2–1.6) of raw and frozen fruit
daily. The most commonly consumed fruits were bananas
followed, in descending order, by apples, oranges, pears,
tangerines and berries (Fig. 1). Low GI fruit accounted for
0.7 servings/day (95% CI 0.5–0.9) and 0.7 servings/day
(95% CI 0.5–0.9) came from higher GI fruit.
At the end of 6 months, participants following the low
GI diet increased their low GI fruit consumption from 0.7
(95% CI 0.6–0.9) to 1.3 (95% CI 1.1–1.5) servings/day
(p<0.001). On the high cereal fibre diet low GI fruit
consumption was reduced from 0.8 (95% CI 0.6–0.9) to 0.3
(95% CI 0.2–0.4) servings/day (p<0.001). Total fruit intake
remained similar on both the low GI and high fibre diets
(2.0 servings/day for both).
On the low GI diet, the change in total fruit and low GI
fruit ranged from −3.5 to 3.0 servings/day and −1.9 to
2.7 servings/day, respectively. On the high fibre diet, the
respective figures were total fruit −3.7 to 3.2 servings/day
and low GI fruit −3.1 to 0.5 servings/day. As this is a
secondary analysis, pooling the data from both treatments
was undertaken. The changes in total fruit and low GI fruit
intake ranged from −3.7 to 3.2 servings per day and −3.1 to
2.7 servings per day, respectively, a substantial span of
approximately six servings of low GI fruit per day.
Relationofchangesintotal andlowGIfruit intaketochanges
in measures of glycaemic control and CHD risk factors No
significant associations were seen between total fruit intake
and changes in measures of glycaemic control and CHD
risk factors.
274 Diabetologia (2011) 54:271–279Low GI fruit intake, expressed as servings, was related to a
reduction in HbA1c (%) (r=−0.206, p=0.011), systolic blood
pressure (r=−0.183, p=0.024) and CHD risk (r=−0.213,
p=0.008). Expressed as a percentage of total carbohydrate
intake there was again a negative relation with HbA1c
(r=−0.218, p=0.007) and calculated CHD risk (r=−0.192,
p=0.018), but a positive relation with HDL-cholesterol
(r=0.216, p=0.008, Table 2).
Controlling for the effect of change in body weight in a
partial correlation analysis did not alter the associations
between the change in low GI fruit as percentage of total
carbohydrate consumed and the reduction in HbA1c
(r=−0.269, r=0.001). This assessment suggested that the
effect of low GI fruit on HbA1c was largely independent of
weight loss.
Relation of changes in individual fruit intake to changes in
measures of glycaemic control and CHD risk factors Indi-
vidually, citrus fruit and berry consumption as a percentage
of total carbohydrate intake was related to a reduction in the
primary outcome, HbA1c (Table 2). Apple consumption
correlated negatively with TG, the total cholesterol/HDL-
cholesterol ratio and CHD risk, and positively with HDL-
cholesterol. Berry intake was related negatively to glucose
and blood pressure but positively to TG. No significant
associations were seen with pear and prunus fruit con-
sumption.
Glycaemic control and body weight in the highest and
lowest quartiles Participants were divided into quartiles
according to the magnitude of their change in low GI fruit
intake across the 6 month treatment period (Electronic
supplementary material [ESM] Tables 1–3). There was a
relative difference of 2.2 servings/day (95% CI 1.9–2.4,
p<0.001) between the changes in low GI fruit intake for the
highest and lowest quartile (ESM Table 3), and an absolute
difference of 1.6 servings/day (95% CI 1.2–1.9, p<0.001)
at the end of the study.
The highest quartile of low GI fruit showed a significantly
greater reduction from baseline in HbA1c (7.2% to 6.5% or a
mean reduction of −0.8% HbA1c units, 95% CI −1, −0.5,
p<0.001) compared with the lowest quartile (7.0% to 6.7%
or a mean reduction of −0.3% HbA1c units, 95% CI −0.5,
−0.1, p=0.01). These two changes were significantly
different from each other, with a mean difference of 0.5%
HbA1c units, 95% CI 0.2–0.8, p<0.001 (equivalent to a
−6% percentage reduction in HbA1c; Fig. 2).
No significant differences were seen in the changes in
body weight or BMI. Even after adjusting the quartiles of
low GI fruit intake according to change in BMI, the
significance of the treatment difference previously observed
in HbA1c remained unaltered. Also, the increase in fibre
intake was greatest in the fourth quartile of low GI fruit
intake. Furthermore, after adjustment for the change in fibre
intake, the increase in low GI fruit was still associated with
an improvement in HbA1c (r=−0.21, p=0.009).
Serum lipids, blood pressure and CHD risk in highest vs
lowest quartiles HDL-cholesterol was significantly in-
creased by 7.3% (95% CI 1.2–13.3%, p=0.019; ESM
Table 3) on the highest quartile of low GI fruit (a change of
0.05 mmol/l, 95% CI 0.03–0.08, p=0.045) compared with
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Diabetologia (2011) 54:271–279 275the lowest quartile (a change of −0.03 mmol/l, 95% CI
−0.15, 0.11, p=0.217). Similarly, the relative reduction in
systolic blood pressure between quartiles was −4% (95% CI
−8, 0%, p=0.044; ESM Table 3), as was the calculated
10 year CHD risk (−13%, 95% CI −23, −3%, p=0.010).
Contribution of low GI fruit to the overall low GI
intervention Assessment of the contribution of the compo-
nents of the low GI diet to the change in HbA1c was carried
out using a regression model, controlling for change in fibre
and total fruit intake. Only low GI fruit and low GI bread
intake were significant predictors (r=−0.233, p=0.0017
and r=−0.228, p=0.002, respectively; Table 3). When both
low GI fruit and low GI bread were assessed in the same
regression model, both independently predicted the change
in HbA1c (p=0.031 and p=0.038, respectively).
Discussion
In this secondary analysis of a low GI study, consumption
of two additional daily servings of low GI fruit (the
difference between the lowest and highest quartiles of
intake) was associated with a significant benefit in
glycaemic control, blood lipids and blood pressure. The
effect of altering the nature of the fruit eaten has not
previously been assessed in diabetes to our knowledge, but
may have benefits for both micro- and macrovascular
disease, the treatment of which is the major therapeutic
goal for type 2 diabetes.
Despite dietary advice to the general public to eat more
fruit and vegetables and encouraging data from cohort
studies indicating less cardiovascular and cerebrovascular
disease [12, 22–25], the results of the few randomised
controlled trials of the impact on cardiovascular disease and
cancer have been disappointing [26–29]. However, fruit
advice has been general and has not focused on low GI fruit
[26–29].
On the other hand, very small increases in fructose intake
of 7–10 g (a ‘catalytic’ amount) have been shown to prime
glucose metabolism, reducing postprandial glucose concen-
trations [30–33] and increasing liver glycogen synthesis
threefold by increasing flux through glycogen synthase,
assessed by magnetic resonance spectroscopy [34]. At the
Table 2 Association of low GI fruit intake with study measurements in 152 completers
Study outcomes %Δ
week 24–0
Value Change in fruit intake (% of total available carbohydrate intake)
Apples Citrus (oranges,
tangerines, grapefruits
Berries (strawberries,
raspberries, blueberries,
blackberries, cranberries)
Pears Prunus family (plum,
peaches, nectarines)
Total low
GI fruit
HbA1c r −0.135 −0.219 −0.228 0.121 −0.073 −0.218
p 0.096 0.007 0.005 0.136 0.372 0.007
Glucose r −0.125 −0.008 −0.167 −0.014 −0.030 −0.141
p 0.124 0.918 0.040 0.863 0.715 0.083
Weight r −0.016 0.112 −0.096 0.123 −0.136 −0.014
p 0.846 0.170 0.239 0.132 0.095 0.865
Total cholesterol r −0.098 −0.001 0.019 −0.052 0.103 −0.020
p 0.228 0.990 0.813 0.522 0.208 0.804
LDL-cholesterol r 0.013 −0.007 −0.070 −0.009 0.059 0.007
p 0.872 0.928 0.395 0.911 0.473 0.930
HDL-cholesterol r 0.223 0.156 −0.105 0.098 0.060 0.216
p 0.006 0.055 0.199 0.231 0.459 0.008
TG r −0.210 −0.069 0.233 −0.090 0.103 −0.070
p 0.009 0.396 0.004 0.268 0.208 0.394
C-reactive protein r 0.031 −0.004 −0.071 0.151 0.050 0.065
p 0.716 0.960 0.403 0.075 0.559 0.443
Systolic blood pressure r −0.017 −0.006 −0.302 −0.035 −0.034 −0.122
p 0.839 0.940 0.000 0.666 0.682 0.134
Diastolic blood pressure r −0.017 −0.140 −0.162 0.035 0.069 −0.067
p 0.833 0.086 0.046 0.667 0.400 0.410
CHD risk r −0.211 −0.089 −0.067 −0.099 0.039 −0.192
p 0.009 0.274 0.409 0.223 0.635 0.018
276 Diabetologia (2011) 54:271–279same time, it has also been demonstrated that low-dose
fructose infusion restores the inhibitory effect of hyper-
glycaemia in reducing net hepatic glucose output in type 2
diabetes, possibly by increasing fructose-1-phosphate. In
turn, fructose-1-phosphate displaces glucokinase from its
nuclear regulatory protein and allows its translocation to the
cell surface to facilitate portal glucose uptake and its
retention within hepatocytes [35]. It may be, therefore, that
the increase in low GI fruit, by releasing an additional 6 g
or more of fructose from the small intestine into the
circulation over an extended period of time, has a
disproportionately large effect in reducing postprandial
blood glucose excursions.
The situation is very different for large amounts of
fructose (17–25% of dietary energy intake) incorporated
into sweetened beverages, baked goods and breakfast
cereals [6, 36–40]. Early on, high fructose intakes were
associated with increased TG levels [36]. Later studies
noted increases in LDL-cholesterol [6, 37, 38]. Most
recently, raised postprandial TG responses have been
reported after high fructose consumption, especially in
men, together with increased remnant particle concentra-
tions, more visceral fat and impaired carbohydrate tolerance
[6]. These effects of high fructose intake over time would
be expected to increase the risk of diabetes and cardiovas-
cular disease. At more modest intake levels, sucrose and
fructose intake have not been associated with increased
CHD risk [41–43].
Fruits in general are also sources of fibre, minerals,
antioxidants and phenolics, which may reduce serum lipids
and oxidative damage, lower blood pressure, improve
diabetes control and, over time, decrease CHD outcomes.
However, definitive roles for all these components remain
to be established [44–48]. Furthermore their relevance to
the present study is less clear as it was the nature (GI) rather
than the quantity of fruit eaten that was altered. On the
other hand, cohort studies have assessed the effect of
dietary GI on diabetes incidence and CHD [41–43, 49, 50]
and significant positive associations have been found in the
larger studies [41, 49, 50]. Nevertheless, the nature of the
individual fruit consumed was not reported in these studies
[41–43, 49, 50].
A weakness of the present study may be seen as singling
out low GI fruit for detailed assessment when low GI fruit
consumption was only one of the strategies used to reduce
the overall GI of the diet. Nevertheless, in regression
analysis involving all eight components of the low GI diet,
low GI fruit intake was one of only two independent
determinants of change in HbA1c. This association
remained even after adjustment for fibre and total fruit
intake. In addition, weight loss was also present on both the
low GI and high fibre treatments. However, correction for
body weight change in a partial regression analysis did not
alter the significance of associations previously seen with
simple Pearson correlations between low GI fruit intake and
HbA1c and calculated CHD risk. Finally, although fruits are
of special interest for a number of reasons, including their
role as a natural source of fructose in the diet, there has
been great difficulty in increasing fruit intake, despite
universal advice to the public.
The strengths of the study included the first attempt to
define the health benefits of individual fruit in type 2 diabetes,
the detailed dietary recording—which has allowed the type of
fruit consumed in the diet to be clearly identified and the
amountsdetermined—andthesubstantialparticipantnumbers,
which enabled statistical significance to be established.
In conclusion, the data suggest that selection of low GI
fruit is associated with improvement in HbA1c.S u c h
changes may also favourably affect HDL-cholesterol, blood
pressure and overall CHD risk. Further studies are required
to confirm these findings and determine optimal levels of
fruit consumption to maximise glycaemic control.
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Fig. 2 Changes in HbA1c (%) for four quartiles of change in low GI
fruit intake. The difference between extremes of quartiles (quartile 1
vs quartile 4) was significant (p=0.001). Within-treatment differences
were assessed by paired t test (*p≤0.05 and ***p≤0.001). Different
coloured bars with quartile numbers at the top of the bars represent
different quartiles of change in low GI fruit intake
Table 3 Regression analysis of total fruit, fibre and key low GI diet
components against change in HbA1c
Key diet
components
a
Adjusted r Regression model,
p value
Key component,
p value
Low GI fruit −0.233 0.011 0.0017
Low GI bread −0.228 0.012 0.002
Parboiled rice −0.069 0.299 0.124
Legumes −0.047 0.346 0.157
Low GI cereal −0.032 0.372 0.176
Pasta −0.050 0.456 0.252
Bulgar −0.052 0.462 0.258
Barley −0.101 0.689 0.672
aAll models were adjusted for change in fibre (g/kJ or kcal) and total fruit
(% of available carbohydrate) intake
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